Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus
NEW YORK, January 1, 2026, 10:07 ET — Market closed Disc Medicine, Inc. shares rose 3.3% to $79.41 in the last U.S. trading session of 2025, before Wall Street shut on Thursday for the New Year’s Day holiday. Investors are focused on a U.S. Food and Drug Administration decision expected by the end of January on Disc’s lead drug candidate bitopertin for erythropoietic protoporphyria, or EPP, a rare genetic disease in which light exposure can trigger severe pain. Investing.com Australia The ruling is being watched beyond Disc because bitopertin is among the early drugs tapped for the FDA’s Commissioner’s National